PharmaNet Development Group

Catherine Derasp, RN, has joined PharmaNet Development Group as vice president, Clinical Operations of Phase I clinics.

Ms. Derasp will oversee the management of the Company’s 350 bed Phase I clinical operations that are located in Montreal and Quebec City, Canada. In addition to first-in-man and proof-of-concept phase I clinical services, Ms. Derasp will be responsible for a variety of studies in special populations, cardiac safety testing, and drug-drug interaction studies.

“We are thrilled to have Catherine join us,” said Riaz Bandali, president, Early Stage Development. “Catherine’s commitment to continual improvement and expertise in multi-site Phase I clinical operations, quality systems, and training brings the right combination of knowledge and experience to the PharmaNet Phase I clinical organization.”

Ms. Derasp has more than 15 years of experience working for Phase I clinical research organizations. Her various leadership roles included managing global multi-site operations with specialization in operational quality and process improvement.